Neural precursor cells as a novel target for interferon-beta

Neuropharmacology

Volumn 56, Issue 2, 2009, Pages 386-398

  Wellen, Jennifer ^a   Walter, Janine ^a   Jangouk, Parastoo ^a   Hartung, Hans Peter ^a   Dihné, Marcel ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Development; Differentiation; Interferon; Neural precursor cells; Proliferation

Indexed keywords

BETA INTERFERON; INTERFERON RECEPTOR; PROTEIN P21; TUMOR NECROSIS FACTOR ALPHA; VIPER VENOM; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION REGULATION; MOUSE; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEURAL STEM CELL; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION;

ANIMALS; CASPASE 3; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EMBRYO, MAMMALIAN; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; IMMUNOLOGIC FACTORS; INTERFERON-BETA; MICE; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; RECEPTORS, INTERFERON; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 58549096289     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2008.09.011     Document Type: Article

References (55)

1. Arvidsson A., Collin T., Kirik D., Kokaia Z., and Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nat. Med. 8 (2002) 963-970
2. Baccala R., Hoebe K., Kono D.H., Beutler B., and Theofilopoulos A.N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13 (2007) 543-551
3. Barkho B.Z., Song H., Aimone J.B., Smrt R.D., Kuwabara T., Nakashima K., Gage F.H., and Zhao X. Identification of astrocyte-expressed factors that modulate neural stem/progenitor cell differentiation. Stem Cells Dev. 15 (2006) 407-421
4. Belmadani A., Tran P.B., Ren D., and Miller R.J. Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 26 (2006) 3182-3191
5. Ben-Hur T., Ben-Menachem O., Furer V., Einstein O., Mizrachi-Kol R., and Grigoriadis N. Effects of proinflammatory cytokines on the growth, fate, and motility of multipotential neural precursor cells. Mol. Cell. Neurosci. 24 (2003) 623-631
6. Ben-Hur T., Ben-Yosef Y., Mizrachi-Kol R., Ben-Menachem O., and Miller A. Cytokine-mediated modulation of MMPs and TIMPs in multipotential neural precursor cells. J. Neuroimmunol. 175 (2006) 12-18
7. Borden E.C., Lindner D., Dreicer R., Hussein M., and Peereboom D. Second-generation interferons for cancer: clinical targets. Semin. Cancer Biol. 10 (2000) 125-144
8. Bruck W., Lucchinetti C., and Lassmann H. The pathology of primary progressive multiple sclerosis. Mult. Scler. 8 (2002) 93-97
9. Butovsky O., Ziv Y., Schwartz A., Landa G., Talpalar A.E., Pluchino S., Martino G., and Schwartz M. Microglia activated by IL-4 or IFN-gamma differentially induce neurogenesis and oligodendrogenesis from adult stem/progenitor cells. Mol. Cell. Neurosci. 31 (2006) 149-160
10. Cacci E., Claasen J.H., and Kokaia Z. Microglia-derived tumor necrosis factor-alpha exaggerates death of newborn hippocampal progenitor cells in vitro. J. Neurosci. Res. 80 (2005) 789-797
11. Cho S.G., Yi S.Y., and Yoo Y.S. IFNgamma and TNFalpha synergistically induce neurite outgrowth on PC12 cells. Neurosci. Lett. 378 (2005) 49-54
12. Conti L., Pollard S.M., Gorba T., Reitano E., Toselli M., Biella G., Sun Y., Sanzone S., Ying Q.L., Cattaneo E., and Smith A. Niche-independent symmetrical self-renewal of a mammalian tissue stem cell. PLoS Biol. 3 (2005) e283
13. Deleyrolle L., Marchal-Victorion S., Dromard C., Fritz V., Saunier M., Sabourin J.C., Tran Van Ba C., Privat A., and Hugnot J.P. Exogenous and fibroblast growth factor 2/epidermal growth factor-regulated endogenous cytokines regulate neural precursor cell growth and differentiation. Stem Cells 24 (2006) 748-762
14. Einhorn S., and Grander D. Why do so many cancer patients fail to respond to interferon therapy?. J. Interferon Cytokine Res. 16 (1996) 275-281
15. Ferrantini M., Capone I., and Belardelli F. Interferon-alpha and cancer: mechanisms of action and new perspectives of clinical use. Biochimie 89 (2007) 884-893
16. Frohman E.M., Racke M.K., and Raine C.S. Multiple sclerosis - the plaque and its pathogenesis. N. Engl. J. Med. 354 (2006) 942-955
17. Garrison J.I., Berens M.E., Shapiro J.R., Treasurywala S., and Floyd-Smith G. Interferon-beta inhibits proliferation and progression through S phase of the cell cycle in five glioma cell lines. J. Neurooncol. 30 (1996) 213-223
18. Gosselin D., and Rivest S. Role of IL-1 and TNF in the brain: twenty years of progress on a Dr. Jekyll/Mr. Hyde duality of the innate immune system. Brain Behav. Immun. 21 (2007) 281-289
19. Gutterman J.U. Cytokine therapeutics: lessons from interferon alpha. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1198-1205
20. Hargus G., Cui Y., Schmid J.S., Xu J., Glatzel M., Schachner M., and Bernreuther C. Tenascin-R promotes neuronal differentiation of embryonic stem cells and recruitment of host-derived neural precursor cells after excitotoxic lesion of the mouse striatum. Stem Cells (2008)
21. Iosif R.E., Ekdahl C.T., Ahlenius H., Pronk C.J., Bonde S., Kokaia Z., Jacobsen S.E., and Lindvall O. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J. Neurosci. 26 (2006) 9703-9712
22. Kajiwara K., Ogata S., and Tanihara M. Promotion of neurite outgrowth from fetal hippocampal cells by TNF-alpha receptor 1-derived peptide. Cell Transplant. 14 (2005) 665-672
23. Kappos L., and Hartung H.P. 10 years of interferon beta-1b (Betaferon) therapy. J. Neurol. 252 Suppl. 3 (2005) iii1-iii2
24. Kazanis I., Belhadi A., Faissner A., and Ffrench-Constant C. The adult mouse subependymal zone regenerates efficiently in the absence of tenascin-C. J. Neurosci. 27 (2007) 13991-13996
25. Kieseier B.C., and Hartung H.P. Current disease-modifying therapies in multiple sclerosis. Semin. Neurol. 23 (2003) 133-146
26. Kieseier B.C., Wiendl H., Hemmer B., and Hartung H.P. Treatment and treatment trials in multiple sclerosis. Curr. Opin. Neurol. 20 (2007) 286-293
27. Kim S.J., Son T.G., Kim K., Park H.R., Mattson M.P., and Lee J. Interferon-gamma promotes differentiation of neural progenitor cells via the JNK pathway. Neurochem. Res. 32 (2007) 1399-1406
28. Kim Y.J., Hwang S.Y., Hwang J.S., Lee J.W., Oh E.S., and Han I.O. C6 glioma cell insoluble matrix components enhance IFN-gamma-stimulated INOS/no production in BV2 microglial cells. J. Biol. Chem. (2007)
29. Koch M., May U., Kuhns S., Drechsler H., Adam N., Hattermann K., Wirtz S., Rose-John S., and Scheller J. Interleukin 27 induces differentiation of neural C6-precursor cells into astrocytes. Biochem. Biophys. Res. Commun. 364 (2007) 483-487
30. Koo J.W., and Duman R.S. IL-1beta is an essential mediator of the antineurogenic and anhedonic effects of stress. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 751-756
31. Menn B., Garcia-Verdugo J.M., Yaschine C., Gonzalez-Perez O., Rowitch D., and Alvarez-Buylla A. Origin of oligodendrocytes in the subventricular zone of the adult brain. J. Neurosci. 26 (2006) 7907-7918
32. Miller D.H., Barkhof F., Frank J.A., Parker G.J., and Thompson A.J. Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance. Brain 125 (2002) 1676-1695
33. Mocellin S., and Nitti D. TNF and cancer: the two sides of the coin. Front. Biosci. 13 (2008) 2774-2783
34. Monje M.L., Toda H., and Palmer T.D. Inflammatory blockade restores adult hippocampal neurogenesis. Science 302 (2003) 1760-1765
35. Munoz-Fernandez M.A., and Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 56 (1998) 307-340
36. Narayanan S., De Stefano N., Francis G.S., Arnaoutelis R., Caramanos Z., Collins D.L., Pelletier D., Arnason B.G.W., Antel J.P., and Arnold D.L. Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. J. Neurol. 248 (2001) 979-986
37. Natsume A., Mizuno M., Ryuke Y., and Yoshida J. Antitumor effect and cellular immunity activation by murine interferon-beta gene transfer against intracerebral glioma in mouse. Gene Ther. 6 (1999) 1626-1633
38. Natsume A., Tsujimura K., Mizuno M., Takahashi T., and Yoshida J. IFN-beta gene therapy induces systemic antitumor immunity against malignant glioma. J. Neurooncol. 47 (2000) 117-124
39. Neumann H., Schweigreiter R., Yamashita T., Rosenkranz K., Wekerle H., and Barde Y.A. Tumor necrosis factor inhibits neurite outgrowth and branching of hippocampal neurons by a rho-dependent mechanism. J. Neurosci. 22 (2002) 854-862
40. Perwez Hussain S., and Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int. J. Cancer 121 (2007) 2373-2380
41. Qin X.Q., Beckham C., Brown J.L., Lukashev M., and Barsoum J. Human and mouse IFN-beta gene therapy exhibits different anti-tumor mechanisms in mouse models. Mol. Ther. 4 (2001) 356-364
42. Radisky E.S., and Radisky D.C. Stromal induction of breast cancer: inflammation and invasion. Rev. Endocr. Metab. Disord. 8 (2007) 279-287
43. Randall R.E., and Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89 (2008) 1-47
44. Rudick R.A., Fisher E., Lee J.C., Simon J., Jacobs L., and Multiple Sclerosis Collaborative Research Group. Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Neurology 53 (1999) 1698-1704
45. Sanai N., Tramontin A.D., Quinones-Hinojosa A., Barbaro N.M., Gupta N., Kunwar S., Lawton M.T., McDermott M.W., Parsa A.T., Manuel-Garcia Verdugo J., Berger M.S., and Alvarez-Buylla A. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature 427 (2004) 740-744
46. Sarkar F.H., and Li Y. NF-kappaB: a potential target for cancer chemoprevention and therapy. Front. Biosci. 13 (2008) 2950-2959
47. Sattler M.B., Demmer I., Williams S.K., Maier K., Merkler D., Gadjanski I., Stadelmann C., Bahr M., and Diem R. Effects of interferon-beta-1a on neuronal survival under autoimmune inflammatory conditions. Exp. Neurol. 201 (2006) 172-181
48. Song J.H., Wang C.X., Song D.K., Wang P., Shuaib A., and Hao C. Interferon gamma induces neurite outgrowth by up-regulation of p35 neuron-specific cyclin-dependent kinase 5 activator via activation of ERK1/2 pathway. J. Biol. Chem. 280 (2005) 12896-12901
49. Vescovi A.L., Galli R., and Reynolds B.A. Brain tumour stem cells. Nat. Rev. Cancer 6 (2006) 425-436
50. Widera D., Kaus A., Kaltschmidt C., and Kaltschmidt B. Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?. J. Cell. Mol. Med. (2007)
51. Widera D., Mikenberg I., Elvers M., Kaltschmidt C., and Kaltschmidt B. Tumor necrosis factor alpha triggers proliferation of adult neural stem cells via IKK/NF-kappaB signaling. BMC Neurosci. 7 (2006) 64
52. Wong G., Goldshmit Y., and Turnley A.M. Interferon-gamma but not TNF alpha promotes neuronal differentiation and neurite outgrowth of murine adult neural stem cells. Exp. Neurol. 187 (2004) 171-177
53. Wu J.P., Kuo J.S., Liu Y.L., and Tzeng S.F. Tumor necrosis factor-alpha modulates the proliferation of neural progenitors in the subventricular/ventricular zone of adult rat brain. Neurosci. Lett. 292 (2000) 203-206
54. Yoshida J., and Mizuno M. Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma. J. Neurooncol. 65 (2003) 261-267
55. Yoshida J., Mizuno M., and Wakabayashi T. Interferon-beta gene therapy for cancer: basic research to clinical application. Cancer Sci. 95 (2004) 858-865